← Insider buys
AKRO

Akero Therapeutics, Inc. · HEALTHCARE

Versant Venture Capital Vi, L.P. sold $1.2M of Akero Therapeutics, Inc.

10% owner

Sold$1,242,403
$20.87Price
59,532Shares
−2%Stake

What AKRO did after the filing

Prices for AKRO after this filing aren't in yet.

Traded Thu, Jan 16. Filed Tue, Jan 21, 4:57 PM ET, after the close. Not investment advice.